Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print October 19, 2005, doi:10.1212/01.wnl.0000187313.83515.7e)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 65, Number 11, December 13, 2005
Right arrow All Versions of this Article:
01.wnl.0000187313.83515.7ev1
65/11/1792    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Videnovic, A.
Right arrow Articles by Raizer, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Videnovic, A.
Right arrow Articles by Raizer, J. J.
Related Collections
Right arrow MRI
Right arrow All Oncology
Right arrow Chemotherapy-tumor
NEUROLOGY 2005;65:1792-1794
© 2005 American Academy of Neurology
Brief Communications

Capecitabine-induced multifocal leukoencephalopathy: A report of five cases

A. Videnovic, MD, I. Semenov, MD, R. Chua-Adajar, MD, L. Baddi, MD, D. T. Blumenthal, MD, A. C. Beck, MD, T. Simuni, MD, S. Futterer, MD, W. Gradishar, MD, C. Tellez, MD and J. J. Raizer, MD

From the Davee Department of Neurology and Neurological Sciences (Drs. Videnovic, Semenov, Chua-Adajar, Simuni, Raizer), Department of Radiology, Section of Neuroradiology (Dr. Futterer), Northwestern University, Feinberg School of Medicine; Department of Medicine (Drs. Baddi, Gradishar, Tellez), Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, IL; Departments of Neurology, Neurosurgery and Medicine, Division of Oncology, Huntsman Cancer Institute (Dr. Blumenthal) and Utah Cancer Specialists, Department of Medicine (Dr. Beck), University of Utah, Salt Lake City.

Capecitabine is used to treat advanced breast and gastrointestinal malignancies. A single case of encephalopathy and three cases of peripheral neuropathy are the only neurotoxicities reported. The authors report five additional cases of capecitabine-induced multifocal leukoencephalopathy.

Commentary, see page 1685

This article was previously published in electronic format as an Expedited E-Pub on October 19, 2005, at www.neurology.org.

Disclosure: The authors report no conflicts of interest.

Received June 15, 2005. Accepted in final form September 13, 2005.

Address correspondence and requests reprints to Dr. Jeffrey J. Raizer, Davee Department of Neurology and Neurological Sciences, Northwestern University, Feinberg School of Medicine, 710 North Lake Shore Drive, Abbott Hall, Room 1123, Chicago, IL 60611; e-mail: Jraizer{at}nmff.org




This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
M. S. H. Lam, D. A. Kaufman, and M. P. Russin
Capecitabine-associated cerebellar ataxia
Am. J. Health Syst. Pharm., November 1, 2008; 65(21): 2032 - 2035.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
J M Baehring and R K Fulbright
Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients
J. Neurol. Neurosurg. Psychiatry, May 1, 2008; 79(5): 535 - 539.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.